US Equity
FATE
— FATE THERAPEUTICS, INC.Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing off-the-shelf cellular immunotherapies for cancer and immune disorders.
💰 Market cap: $283.24M📍 12278 Scripps Summit Drive, SAN DIEGO, CA, 92131 US🏷️ Biotechnology & Medical Research💵 Previous close: $2.41🔢 8,964 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $2.41 |
| 2026-07-23 | $2.52 |
| 2026-07-22 | $2.58 |
| 2026-07-21 | $2.83 |
| 2026-07-20 | $2.79 |
| 2026-07-17 | $2.78 |
| 2026-07-16 | $2.73 |
| 2026-07-15 | $2.99 |
| 2026-07-14 | $2.99 |
| 2026-07-13 | $3.02 |
| 2026-07-10 | $3.10 |
| 2026-07-09 | $3.11 |
| 2026-07-08 | $2.93 |
| 2026-07-07 | $3.02 |
| 2026-07-06 | $2.99 |
| 2026-07-02 | $2.92 |
| 2026-07-01 | $3.02 |
| 2026-06-30 | $2.70 |
| 2026-06-29 | $2.42 |
| 2026-06-26 | $2.10 |
| 2026-06-25 | $1.87 |
| 2026-06-24 | $2.06 |
| 2026-06-23 | $2.16 |
| 2026-06-22 | $2.15 |
| 2026-06-18 | $2.09 |
| 2026-06-17 | $1.96 |
| 2026-06-16 | $1.90 |
| 2026-06-15 | $2.01 |
| 2026-06-12 | $2.06 |
| 2026-06-11 | $1.97 |
| 2026-06-10 | $1.87 |
| 2026-06-09 | $1.90 |
| 2026-06-08 | $1.91 |
| 2026-06-05 | $1.98 |
| 2026-06-04 | $2.21 |
| 2026-06-03 | $2.22 |
| 2026-06-02 | $2.57 |
| 2026-06-01 | $2.74 |
| 2026-05-29 | $2.84 |
| 2026-05-28 | $2.63 |
| 2026-05-27 | $2.37 |
| 2026-05-26 | $2.15 |
| 2026-05-22 | $2.25 |
| 2026-05-21 | $2.10 |
| 2026-05-20 | $1.84 |
| 2026-05-19 | $1.89 |
| 2026-05-18 | $1.73 |
| 2026-05-15 | $1.75 |
| 2026-05-14 | $1.90 |
| 2026-05-13 | $2.13 |
| 2026-05-12 | $2.25 |
| 2026-05-11 | $2.18 |
| 2026-05-08 | $2.39 |
| 2026-05-07 | $2.43 |
| 2026-05-06 | $2.29 |
| 2026-05-05 | $2.36 |
| 2026-05-04 | $1.80 |
| 2026-05-01 | $1.53 |
| 2026-04-30 | $1.25 |
| 2026-04-29 | $1.24 |
| 2026-04-28 | $1.30 |